41
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7181 |
IDO-IN-1
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO-IN-1 是吲哚胺-2,3-双加氧酶抑制剂,IC50=59 nM。 | |||
T11901 |
IDO1-IN-5
|
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-5 是可透过血脑屏障的、选择性的IDO1抑制剂,能够与缺乏血红素的 apo-IDO1 结合,但无法与成熟血红素的 IDO1 结合。 | |||
T4142 |
PCC0208009
IDO inhibitor 1,DO-IN-2,IDO-IN-2 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
PCC0208009 (IDO-IN-2) 是一种有效的 IDO 抑制剂,其在 HeLa 细胞中的 IC50=4.52 nM。它调节 ACC 和杏仁核的突触可塑性,减少神经性疼痛和合并症。 | |||
T11623 |
IDO/TDO-IN-1
|
Others | Others |
IDO/TDO-IN-1 is an orally active dual indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) inhibitor (IC50s: 9.7 and 47 nM). | |||
T39888 |
IDO1-IN-7
IDO1-IN-7 |
||
IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research. | |||
T39839 |
IDO1-IN-11
IDO1-IN-11 |
||
IDO1-IN-11 is an IDO1 inhibitor with an IC 50 value of 0.6 nM. | |||
T39946 |
IDO1-IN-12
IDO1-IN-12 |
||
IDO1-IN-12 is a potent and orally available IDO1 inhibitor. | |||
T20513 |
IDO1-IN-1
IDO1 inhibitor 1,2 HzBTZ,2-肼基苯并噻唑,IDO1IN1,2-HzBTZ,IDO1-inhibitor-1 |
IDO | Metabolism |
IDO1-IN-1 (2 HzBTZ) 是一种吲哚胺 2,3-双加氧酶 1 (IDO1) 抑制剂。 | |||
T7660 |
IDO inhibitor 1
4-[[2-[(氨基磺酰基)氨基]乙基]氨基]-N'-(3-溴-4-氟苯基)-N-羟基-1,2,5-恶二唑-3-甲脒 |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO inhibitor 1 是一种有效的吲哚胺-2,3 双加氧酶 (IDO) 抑制剂 (IC50 <100 nM)。具有潜在的免疫调节和抗肿瘤活性。 | |||
T11624 | IDO1-IN-2 | IDO | Metabolism |
IDO1-IN-2 is a potent and selective IDO1 inhibitor with IC50s of 81 nM, 59 nM (mouse), and 28 nM (rat), respectively. It has anti-cancer activity. | |||
T12801 |
(S)-IDO1-IN-5
|
Others | Others |
(S)-IDO1-IN-5 is an active S-isomer of IDO1-IN-5. (S)-IDO1-IN-5 binds to IDOL(IC50 value less than 1.5 µΜ). | |||
T12668 |
(Rac)-IDO1-IN-5
|
Others | Others |
(Rac)-IDO1-IN-5 is a racemate of IDO1-IN-5, a potent, selective, and brain-penetrating inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity. It specifically binds to apo-IDO1, which lacks heme, instead of mature heme-bound IDO1. | |||
T37329 |
PROTAC IDO1 Degrader-1
PROTAC IDO1 Degrader-1 |
||
PROTAC IDO1 Degrader-1 is the first potent IDO1 (indoleamine 2,3-dioxygenase 1) degrader that hijacks IDO1 to CRBN E3 ligase to introduce IDO1 into UPS and eventually achieve ubiquitination and degradation (DC50=2.84 μM). PROTAC IDO1 Degrader-1 moderately improves the tumor-killing activity of H ER2 CAR-T cells[1]. PROTAC IDO1 Degrader-1 (compound 2c) (10 μM; 24 hours) notably decreases IDO1 level induced by IFN-γ[1].PROTAC IDO1 Degrader-1 and IFN-γ (5 ng/mL) are incubated with HeLa cells for 24... | |||
T82082 | IDO1-IN-23 | Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-23(化合物41)是一种有效的人类IDO1抑制剂,具备13 μM的IC50值。 | |||
T78687 | IDO1-IN-21 | Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-21(化合物10m)为IDO1抑制剂,其IC50值为0.64 μM。该化合物在小鼠体内可有效抑制肿瘤生长。 | |||
T61944 |
IDO1-IN-15
|
||
IDO1-IN-15 是有效的IDO1抑制剂,IC50为127 nM。IDO1-IN-15与Epacadostat 在体外对抗 IDO1 酶的效力相当。 | |||
T61789 | IDO1-IN-14 | ||
IDO1-IN-14 (compound 4a) is a highly effective inhibitor of the IDO1 enzyme, exhibiting an IC50 value of 396.9 nM. Additionally, IDO1-IN-14 demonstrates excellent suppression of cellular IDO1 activity, as observed in HeLa cells with an EC50 value of 3393 nM [1]. | |||
T74507 |
IDO1-IN-20
|
||
IDO1-IN-20是一种催化色氨酸氧化代谢的酶,能在肿瘤微环境中对肿瘤进行免疫抑制。 | |||
T63814 |
IDO2-IN-1
|
||
IDO2-IN-1 是一种口服活性的强效IDO2抑制剂,其IC50为112 nM。该化合物适用于炎症性自身免疫研究。 | |||
T63034 | IDO1-IN-13 | ||
IDO1-IN-13 (compound 27a) 是一种 IDO1 的有效抑制剂 (IC50: 61.6 nM)。IDO1-IN-13 能够抑制细胞 IDO1,对 HeLa 的 EC50 值为 30 nM。在 SK-OV-3 异种移植肿瘤组织中,IDO1-IN-13 减少了 51% 的 kyn/trp 比率。 | |||
T73111 | IDO1-IN-17 | ||
IDO1-IN-17 (I-4) 是IDO1的抑制剂,其在 hela 细胞中的IC50值为 0.44 μM。 | |||
T63082 |
IDO1-IN-19
|
||
IDO1-IN-19 (Compound 17) 是一种 IDO1 的有效抑制剂,具有潜力进行癌症疾病的研究。 | |||
T63780 |
IDO1-IN-16
|
||
IDO1-IN-16 (I-1) 是一种 IDO1 抑制剂,能够靶向holo-IDO1 (IC50: 127 nM)。 | |||
T78975 |
IDO1-IN-22
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1-IN-22(Compound 3)是一种效能显著的IDO1抑制剂,具备低纳摩尔级生化活性(hIDO1 IC50:67.4 nM)以及显著的细胞内抑制效果(HeLa细胞中hIDO1 IC50:17.6 nM)。在小鼠LLC异种移植模型中表现出卓越的抗肿瘤效果,并表现出有利的药代动力学(PK)特性。 | |||
T62638 |
IDO1-IN-18
|
||
IDO1-IN-18 (Compound 14) 是一种 IDO1 的有效抑制剂。IDO1-IN-18 具有潜力进行癌症疾病的研究。 | |||
T61385 |
IDO1/TDO-IN-1
|
||
IDO1/TDO-IN-1 (30) is a highly effective inhibitor that targets both IDO1 and TDO enzymes with uncompetitive (Ki = 0.23 μM) and competitive (Ki = 0.73 μM) mechanisms, respectively. This compound, IDO1/TDO-IN-1 (30), exhibits a significant capacity to induce cell apoptosis via the potential mitochondria-mediated Bcl-2/Bax pathway [1]. | |||
T63222 | IDO1/2-IN-1 | ||
IDO1/2-IN-1 是一个有效的、口服具有活力的 IDO1/IDO2 双重抑制剂,对 IDO1 和 IDO2 的IC50分别为 28 nM 和 144 nM,表现出抗肿瘤作用。 | |||
T78795 |
IDO1/TDO-IN-6
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO1/TDO-IN-6(compound 11)为IDO1/TDO双重抑制剂,其IC50值分别为2.25 μM和2.89 μM。在抑制IDO1和TDO方面,其Ki值分别为1.9 μM和3.1 μM。IDO1/TDO-IN-6适用于癌症与免疫学领域的研究。 | |||
T63651 | IDO1/2-IN-1 hydrochloride | ||
IDO1/2-IN-1 hydrochloride 是一个有效的 IDO1 (IC50: 28 nM) 和 IDO2 (IC50: 144 nM) 双重抑制剂,口服具有活力。IDO1/2-IN-1 hydrochloride 表现出抗肿瘤作用。 | |||
T60499 |
IDO1/TDO-IN-2
|
||
IDO1/TDO-IN-2 (Compound 1) 是有效的IDO1/TDO 双重抑制剂,IC50s 分别为 0.1 和 0.07 μM,具有癌症研究的潜力。 | |||
T61140 |
IDO1/TDO-IN-3
|
||
IDO1/TDO-IN-3 is a powerful inhibitor targeting IDO1 and TDO enzymes. It displays noteworthy effectiveness against IDO1 (IC50: 0.005 μM) and TDO (IC50: 0.004 μM). Additionally, IDO1/TDO-IN-3 demonstrates considerable in vivo anti-tumor properties while exhibiting no apparent toxicity [1]. | |||
T60318 | IDO1/TDO-IN-4 | ||
IDO1/TDO-IN-4 显示出对 IDO1 (IC50 = 3.53 μM) 和 TDO (IC50 = 1.15 μM) 的有效抑制作用,并且具有可接受的安全性和药代动力学特性。IDO1/TDO-IN-4 可与 IDO1 形成氢键,与 TDO 产生 π-π 堆积相互作用。 IDO1/TDO-IN-4 可用于抑郁症以及炎症引起的抑郁症的研究。 | |||
T11616 |
IDO-IN-13
GS-4361 |
IDO; Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
IDO-IN-13 (GS-4361) 是 indoleamine 2,3-dioxygenase 1 抑制剂,EC50=17 nM。 | |||
T11619 |
IDO-IN-5
NLG-1489 |
IDO | Metabolism |
IDO-IN-5 is an indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50: 1-10 μM). | |||
T11618 |
IDO-IN-4
|
Others | Others |
IDO-IN-4 is an indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor. | |||
T11621 |
IDO-IN-8
NLG-1487 |
IDO | Metabolism |
IDO-IN-8 is an indoleamine 2,3-dioxygenase (IDO) inhibitor (IC50: 1-10 μM). | |||
T39089 |
Acid secretion-IN-1
|
||
Acid secretion-IN-1, a polycyclic compound, is synthesized for its application as an IDO inhibitor in synthetic experiments. | |||
T72056 |
KYN-101
|
||
KYN-101是一种高效、选择性的芳香烃受体(AHR)合成拮抗剂,在人HepG2 DRE 荧光素酶报告基因检测中IC50为22 nM,在小鼠Hepa1 Cyp-luc 检测中IC50为23 nM。KYN-101逆转IDO/TDO 介导的肿瘤进展,提高PD-1阻断B16 IDO 荷瘤小鼠和表达内源性高水平IDO 的CT26结直肠癌模型的疗效。 | |||
T74536 | IDO/Tubulin-IN-2 | ||
IDO/Tubulin-IN-2 (HT2) 是一种对TDO和微管蛋白 (tubulin)展现出高效抑制作用的化合物。该抑制剂对多种癌细胞系(包括U87、HepG2、A549、HCT-116和LO2)均表现出强抗肿瘤活性,其半抑制浓度(IC50)分别为0.43、0.036、0.041、0.095和1.04 μM,有效提升了抗肿瘤效果。 | |||
T38276 |
Benzomalvin C
|
||
Benzomalvin C is a weak antagonist of the neurokinin-1 (NK1) receptor inhibiting binding of substance P by 46% when used at 100 μg/ml in vitro. It is also a weak inhibitor of indolamine 2,3-dioxygenase (IDO) with an IC50 value of 130 μM for recombinant IDO. It was isolated from Penicillium and contains an epoxide group at C-19 and C-20, which is not present in benzomalvins A, B, or E. | |||
T40211 |
eIF4E-IN-1
eIF4E-IN-1 |
||
eIF4E-IN-1 (WO2021003194A1, compound Y), is a highly effective inhibitor of eIF4E, a key protein involved in immunosuppression. By targeting immune checkpoint proteins such as PD-1, PD-L1, LAG3, TIM3, and IDO, eIF4E-IN-1 functions to disrupt immune suppression and promote immune release in specific diseases such as cancer and infectious diseases. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4S0051 |
Coptisine sulfate
|
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Coptisine Sulfate 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。 | |||
T5S0802 |
Palmatine
巴马汀,Berbericinine,Burasaine |
Indoleamine 2,3-Dioxygenase (IDO); AChR; AChE; Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Metabolism; Neuroscience |
Palmatine (Burasaine) 是口服具有活力的、不可逆IDO-1抑制剂。它可以减轻结肠损伤,预防肠道菌群失调和调节色氨酸分解代谢,从而改善DSS (Dextran Sulphate Sodium Salt) 诱发的结肠炎。它有用于结肠炎的研究潜力。 | |||
T5S0053 |
Coptisine
黄连碱,Coptisin |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Coptisine (Coptisin) 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。 |